Sign In
Buy RVMD
$155.99
+4.68 (+3.09%)
At Close: Jun 03, 2026
Revolution Medicines, Inc. $RVMD Shares Purchased by SG Americas Securities LLC
04:46am, Wednesday, 08'th Apr 2026
SG Americas Securities LLC boosted its holdings in Revolution Medicines, Inc. (NASDAQ: RVMD) by 56.1% during the undefined quarter, according to the company in its most recent filing with the Securiti
These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target
07:35am, Wednesday, 01'st Apr 2026
The GLP-1 revolution has reshaped biopharma M&A strategy. With Novo Nordisk and Eli Lilly generating tens of billions in annual obesity drug revenue, large-cap acquirers are scouring the biotech lands
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of “Buy” by Analysts
02:27am, Saturday, 28'th Mar 2026
Shares of Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) have been given a consensus rating of "Buy" by the twenty-one ratings firms that are presently covering the stock, MarketBeat.com
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound?
12:31pm, Friday, 27'th Mar 2026
Revolution Medicines (RVMD) reported earnings 30 days ago. What's next for the stock?
Revolution Medicines (NASDAQ:RVMD) COO Sells $455,916.84 in Stock
05:52am, Sunday, 22'nd Mar 2026
Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) COO Margaret Horn sold 4,583 shares of the company's stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an
Insider Selling: Revolution Medicines (NASDAQ:RVMD) Insider Sells $427,962.96 in Stock
05:52am, Sunday, 22'nd Mar 2026
Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) insider Stephen Michael Kelsey sold 4,302 shares of the business's stock in a transaction that occurred on Tuesday, March 17th. The shares w
Revolution Medicines (NASDAQ:RVMD) CFO Sells $273,868.44 in Stock
05:06am, Sunday, 22'nd Mar 2026
Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) CFO Jack Anders sold 2,753 shares of the stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $99.48,
REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted c
Algert Global LLC Boosts Position in Revolution Medicines, Inc. $RVMD
03:48am, Tuesday, 17'th Mar 2026
Algert Global LLC boosted its holdings in Revolution Medicines, Inc. (NASDAQ: RVMD) by 141.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission.
General Atlantic L.P. Acquires New Position in Revolution Medicines, Inc. $RVMD
03:50am, Saturday, 14'th Mar 2026
General Atlantic L.P. acquired a new stake in Revolution Medicines, Inc. (NASDAQ: RVMD) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. T
Harbor Health Care ETF Q4 2025 Portfolio Review
08:18am, Wednesday, 11'th Mar 2026
Revolution Medicines was a top contributor during the quarter. AbbVie, by contrast, traded largely sideways, as investors continued to assess its post-patent earnings durability. While Eli Lilly deliv
Fisher Asset Management LLC Buys Shares of 7,305 Revolution Medicines, Inc. $RVMD
03:42am, Monday, 09'th Mar 2026
Fisher Asset Management LLC purchased a new stake in shares of Revolution Medicines, Inc. (NASDAQ: RVMD) during the undefined quarter, according to its most recent 13F filing with the Securities and E
Revolution Medicines, Inc. (RVMD) Presents at TD Cowen 46th Annual Health Care Conference Transcript
11:52am, Tuesday, 03'rd Mar 2026
Revolution Medicines, Inc. (RVMD) Presents at TD Cowen 46th Annual Health Care Conference Transcript
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
10:41am, Thursday, 26'th Feb 2026
Revolution Medicines posts a wider-than-expected Q4 loss and sees 2026 operating expenses of $1.6B-$1.7B as it advances late-stage RAS pipeline studies.
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call Transcript
09:17pm, Wednesday, 25'th Feb 2026
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call Transcript
